122 related articles for article (PubMed ID: 14585369)
1. BAALC, a novel marker of human hematopoietic progenitor cells.
Baldus CD; Tanner SM; Kusewitt DF; Liyanarachchi S; Choi C; Caligiuri MA; Bloomfield CD; de la Chapelle A
Exp Hematol; 2003 Nov; 31(11):1051-6. PubMed ID: 14585369
[TBL] [Abstract][Full Text] [Related]
2. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
[TBL] [Abstract][Full Text] [Related]
3. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro.
Maurer U; Brieger J; Weidmann E; Mitrou PS; Hoelzer D; Bergmann L
Exp Hematol; 1997 Aug; 25(9):945-50. PubMed ID: 9257807
[TBL] [Abstract][Full Text] [Related]
4. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
5. Baalc, a marker of mesoderm and muscle.
Satoskar AA; Tanner SM; Weinstein M; Qualman SJ; de la Chapelle A
Gene Expr Patterns; 2005 Apr; 5(4):463-73. PubMed ID: 15749074
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
[TBL] [Abstract][Full Text] [Related]
7. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.
Georgantas RW; Tanadve V; Malehorn M; Heimfeld S; Chen C; Carr L; Martinez-Murillo F; Riggins G; Kowalski J; Civin CI
Cancer Res; 2004 Jul; 64(13):4434-41. PubMed ID: 15231652
[TBL] [Abstract][Full Text] [Related]
8. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
10. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
11. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
13. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis.
Iversen PO; Wiig H
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6793-9. PubMed ID: 16203766
[TBL] [Abstract][Full Text] [Related]
15. Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage.
Sioud M; Fløisand Y; Forfang L; Lund-Johansen F
J Mol Biol; 2006 Dec; 364(5):945-54. PubMed ID: 17049554
[TBL] [Abstract][Full Text] [Related]
16. CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts.
Ciraci E; Barisani D; Parafioriti A; Formisano G; Arancia G; Bottazzo G; Berardi AC
Exp Hematol; 2007 Jun; 35(6):967-77. PubMed ID: 17533051
[TBL] [Abstract][Full Text] [Related]
17. Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells.
Brunner S; Theiss HD; Murr A; Negele T; Franz WM
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1670-5. PubMed ID: 17911347
[TBL] [Abstract][Full Text] [Related]
18. A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells.
da Silva CL; Gonçalves R; Crapnell KB; Cabral JM; Zanjani ED; Almeida-Porada G
Exp Hematol; 2005 Jul; 33(7):828-35. PubMed ID: 15963859
[TBL] [Abstract][Full Text] [Related]
19. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
20. Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage.
Liu XL; Yuan JY; Zhang JW; Zhang XH; Wang RX
J Leukoc Biol; 2007 Oct; 82(4):986-1002. PubMed ID: 17626799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
